Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients
- PMID: 19012992
- DOI: 10.1016/j.jhep.2008.08.019
Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients
Abstract
Background/aims: To describe in detail the specific clinical and biological characteristics of three patients with MPV17 gene mutations, a rare hepatocerebral mitochondrial DNA depletion syndrome (MDS) and the positive effects of a novel dietetic treatment based on avoidance of fasting.
Methods: We describe the case histories of three members of the same family with MPV17 mutations.
Results: Two patients had a very severe and progressive liver disease: 1 died in the first year of life and the other underwent liver transplantation. The third patient, now 13 years of age, had a milder form of liver disease and developed progressive ataxia. Psychomotor involvement at onset of disease was mild or absent. No patient had severe hyperlactataemia. In vivo functional studies on two patients showed no hyperlactataemia even after intravenous and oral glucose loading, regular fasting hypoglycemia 3-4h after meals and no response to glucagon. Liver function tests improved when patients received continuous iv glucose infusion or were regularly fed every 3h.
Conclusions: These clinical and biochemical features allow us to differentiate patients with MPV17 mutations from other liver MDS and suggest that regular glucose intake at short intervals may be beneficial in slowing the progression of the disease.
Similar articles
-
Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction.Dig Liver Dis. 2009 Jul;41(7):494-9. doi: 10.1016/j.dld.2008.11.013. Epub 2009 Feb 4. Dig Liver Dis. 2009. PMID: 19195941
-
Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency.J Hepatol. 2005 Aug;43(2):333-41. doi: 10.1016/j.jhep.2005.03.023. J Hepatol. 2005. PMID: 15964659
-
Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form.Mol Genet Metab. 2008 Jun;94(2):234-9. doi: 10.1016/j.ymgme.2008.01.012. Epub 2008 Mar 10. Mol Genet Metab. 2008. PMID: 18329934
-
Navajo Neurohepatopathy : A Case Report and Literature Review Emphasizing Clinicopathologic Diagnosis.Acta Gastroenterol Belg. 2016 Sep-Dec;79(4):463-469. Acta Gastroenterol Belg. 2016. PMID: 28209105 Review.
-
[Mitochondrial diseases in children including Leigh syndrome--biochemical and molecular background].Postepy Biochem. 2008;54(2):161-8. Postepy Biochem. 2008. PMID: 18807927 Review. Polish.
Cited by
-
MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile.Front Cell Neurosci. 2021 Mar 17;15:641264. doi: 10.3389/fncel.2021.641264. eCollection 2021. Front Cell Neurosci. 2021. PMID: 33815063 Free PMC article.
-
Functional splicing assay supporting that c.70 + 5G > A mutation in the MPV17 gene is disease causing.J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S293-6. doi: 10.1007/s10545-010-9155-x. Epub 2010 Jul 8. J Inherit Metab Dis. 2010. PMID: 20614188
-
Syndromes associated with mitochondrial DNA depletion.Ital J Pediatr. 2014 Apr 3;40:34. doi: 10.1186/1824-7288-40-34. Ital J Pediatr. 2014. PMID: 24708634 Free PMC article. Review.
-
Gastrointestinal and hepatic manifestations of mitochondrial disorders.J Inherit Metab Dis. 2013 Jul;36(4):659-73. doi: 10.1007/s10545-013-9614-2. Epub 2013 May 15. J Inherit Metab Dis. 2013. PMID: 23674168 Review.
-
Clinical and molecular basis of hepatocerebral mitochondrial DNA depletion syndrome in Japan: evaluation of outcomes after liver transplantation.Orphanet J Rare Dis. 2020 Jul 24;15(1):169. doi: 10.1186/s13023-020-01441-5. Orphanet J Rare Dis. 2020. PMID: 32703289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous